US › Healthcare

Creative Medical Technology Holdings Inc (CELZ)

US · Healthcare · Biotechnology

$0.66+0.34%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Revenue YoY
-100.0%
Net profit
$-1.4M
Profit YoY
+14.2%
EPS
$-0.38
EPS estimate
$-0.39

EPS came in at -0.38 against a street estimate of -0.39 — a beat of 2.6%.

Key statistics

Market cap
$4.3M
Forward P/E
0.0
P/B
0.72
Book value
$1.65
EPS (TTM)
$-2.12
52-week high
$6.25
52-week low
$0.62
50-day MA
$1.56
200-day MA
$2.16
Beta
1.94

Analyst view

Analysts rate Creative Medical Technology Holdings Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $20.00.

Shareholding

Insiders
0.74%
Institutions
5.07%

Largest institutional holders

FundStake
Geode Capital Management, LLC0.81%
Vanguard Capital Management, LLC0.43%
XTX Topco Ltd0.30%
Susquehanna International Group, LLP0.22%
Vanguard Fiduciary Trust Co0.12%
Wells Fargo & Co0.11%
Tower Research Capital LLC0.04%
Morgan Stanley - Brokerage Accounts0.01%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Creative Medical Technology Holdings Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.